Final Meeting (“Proteostatic Mechanisms in Health and Disease“) of the COST Action BM1307 PROTEOSTASIS led by CIC bioGUNE held in Athens (Greece) on the 22-24 February 2018

The Final Meeting counted with the participation of the Action Management Committee and Core Groups members, besides other participants, especially early career investigators (Phd students and post-doctoral fellows). The COST Programme Scientific Officer (Dr. Inga Dadeshidze), who assessed very positively all achievements and results of the Action, also attended the Meeting. We would also like […]

Read More >

Inclusiveness Target Countries (ITC) Conference Grants in the framework of PROTEOSTASIS

nclusiveness Target Countries (ITC) Conference Grants are a new instrument promoted by the COST Programme and aimed at supporting PhD students and ECI researchers from Participating ITC to attend international science and technology related conferences not specifically organised by the COST Action. During the last year of PROTEOSTASIS, our Action has launched an open call […]

Read More >

Professor Frauke Melchior, member of PROTEOSTASIS Working Group 3, has received the 2018 FEBS | EMBO Women in Science Award

Professor Frauke Melchior, an active member of the PROTEOSIS network (Working Group 3), has received the 2018 FEBS | EMBO Women in Science Award. The FEBS | EMBO Women in Science Award recognizes outstanding achievements of female researchers in the life sciences. In addition, winners of the award are role models who inspire future generations […]

Read More >

UbiCODE project kick off meeting and Symposium Ubiquitin Family and Cancer organised in Toulouse(France) between the 6th and 8th February 2018

The Marie Skłodowska-Curie Innovative Training Network  “UbiCODE- European Research Training Network to decipher the ubiquitin code” kick of meeting took place in Toulouse.  UbiCODE aims at training the next generation of researchers in the field of ubiquitin and ubiquitin-like proteins. This project is a reflex of the collaborations and impact of PROTEOSTASIS as it involves several […]

Read More >

CIC bioGUNE, Grant Holder of PROTEOSTASIS, is recognized by the University of the Basque Country (Spain) for its education and training performance

On the 22nd of December 2017, CIC bioGUNE has been recognized by the University of the Basque Country (Spain) for its education and training performance. The University of the Basque Country recognized the work of CIC bioGUNE that each year hosts a very high number of graduates in internships. It was also outlined the importance […]

Read More >

Prof. Arkaitz Carracedo, PROTEOSTASIS WG6 and Translational Projects leader, recognized as Young Talent (“Joven Investigador”) in the field of biomedicine by “CONSTANTES & VITALES”

Prof. Arkaitz Carracedo, PROTEOSTASIS WG6 and Translational Projects leader, received the Young Talent (“Joven Investigador”) Award in the field of biomedicine delivered by “CONSTANTES & VITALES” Spanish Initiative. The award recognizes individuals, born after 1st January 1972, who are leading research groups in Spain and who prove original and relevant contributions in the field of […]

Read More >

Dr. Rosa Barrio, Chair of PROTEOSTASIS, awarded by the FUNDACIÓN INOCENTE INOCENTE for her research work in field of children rare diseases

The work of Dr. Rosa Barrio, Chair of PROTEOSTASIS, in the field of rare diseases was recognized by the Spanish foundation “FUNDACIÓN INOCENTE INOCENTE”. This foundation aims to support activities that promote the quality of life of children facing different health, social and economic problems. In this framework, the foundation launches an annual call to […]

Read More >

Dr. Olivier Coux, Vice-Chair of the Action, disseminated PROTEOSTASIS at the IUBMB Focused Meeting on «Molecular aspects of aging and longevity», held in Athens (Greece) between the 16th and the 19th October 2019

Dr. Olivier Coux, Vice-Chair of the Action, attended the IUBMB Focused Meeting on «Molecular aspects of aging and longevity», held in Athens (Greece) between the 16th and the 19th October 2019. The meeting addressed molecular mechanisms of aging and longevity as a pre-requisite for developing appropriate means of increasing “healthy lifespan”. The Meeting focused on […]

Read More >

Dr. Rosa Barrio, Chair of the Action, disseminates PROTEOSTASIS at the workshop “The key factors for impact in strategic research and innovation funding in a view of widening actions”, held in Tallin (Estonia) between on the 10th-11th October 2017

Dr. Rosa Barrio, Chair of PROTEOSTASIS, has been invited to present the achievement of the Action  at the workshop “The key factors for impact in strategic research and innovation funding in a view of widening actions” organized by the NCP_WIDE.NET  in Tallin (Estonia)  between  on the 10th-11th October 2017.  This workshop was aimed at  providing an overview of […]

Read More >

Dr. Henrique Girão, PROTEOSTASIS MC Member from Portugal and co-leader of WG3, featured in Portuguese press for new and promising strategies to promote cardiac angiogenesis

Dr. Henrique Girão, PROTEOSTASIS MC Member from Portugal and co-leader of WG3, featured in Portuguese press due to his participation in a research project that has identified new and promising strategies to promote cardiac angiogenesis. The research work has  showed that exosomes released by cardiomyocytes subjected to ischemia in vitro can induce the formation of […]

Read More >